Galectin Therapeutics Inc also files under GALT.OB, PRWP.OB, PRWP, PRW, PWRP.OB, 043562325; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Uihlein Richard E | Director, 10% Owner | Option exercise(M) | 2.6M | $4.05 | $10.3M |
| Jul 31, 2026 | Uihlein Richard E | Director, 10% Owner | Option exercise(M) | 31.8M | $3.00 | $95.5M |
| Jul 14, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 16K | $3.04 | $49K |
| Jul 14, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 16K | — | $0 |
| Jul 14, 2026 | Jamil Khurram | Chief Medical Officer | Sell(S) | 16K | $5.13 | $83K |
| Jun 29, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 47K | $2.50 | $119K |
| Jun 29, 2026 | Shlevin Harold H. | Director | Option exercise(M) | 22K | — | $0 |
| Jun 29, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 47K | — | $0 |
| Jun 29, 2026 | Jamil Khurram | Chief Medical Officer | Sell(S) | 47K | $5.04 | $239K |
| Jun 29, 2026 | Shlevin Harold H. | Director | Sell(S) | 22K | $5.04 | $112K |
| Jun 29, 2026 | Shlevin Harold H. | Director | Option exercise(M) | 22K | $1.23 | $27K |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 2K | $2.20 | $4K |
| Jun 26, 2026 | Shlevin Harold H. | Director | Sell(S) | 8K | $5.00 | $39K |
| Jun 26, 2026 | Shlevin Harold H. | Director | Option exercise(M) | 8K | $1.23 | $10K |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 3K | $2.50 | $6K |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Sell(S) | 3K | $5.00 | $13K |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 3K | — | $0 |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 2K | — | $0 |
| Jun 26, 2026 | Jamil Khurram | Chief Medical Officer | Sell(S) | 2K | $5.00 | $10K |
| Jun 26, 2026 | Shlevin Harold H. | Director | Option exercise(M) | 8K | — | $0 |
| Jun 23, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 8K | $1.23 | $9K |
| Jun 23, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 8K | — | $0 |
| Jun 23, 2026 | Jamil Khurram | Chief Medical Officer | Sell(S) | 8K | $3.14 | $24K |
| May 26, 2026 | Jamil Khurram | Chief Medical Officer | Sell(S) | 568 | $3.10 | $2K |
| May 26, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 568 | — | $0 |
| May 26, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 568 | $1.23 | $699 |
| Mar 12, 2026 | Brem Henry | Director | Grant(A) | 60K | — | $0 |
| Feb 6, 2026 | Eldred Kary | Director | Buy(P) | 300 | $2.70 | $810 |
| Jan 16, 2026 | Jamil Khurram | Chief Medical Officer | Grant(A) | 65K | — | $0 |
| Jan 16, 2026 | Jamil Khurram | Chief Medical Officer | Grant(A) | 100K | — | $0 |
| Jan 16, 2026 | Freeman Kevin D | Director | Grant(A) | 60K | — | $0 |
| Jan 16, 2026 | Eldred Kary | Director | Grant(A) | 60K | — | $0 |
| Jan 16, 2026 | Callicutt Jack W | Chief Financial Officer | Grant(A) | 65K | — | $0 |
| Jan 16, 2026 | Callicutt Jack W | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Jan 16, 2026 | Shlevin Harold H. | Director | Grant(A) | 60K | — | $0 |
| Jan 16, 2026 | Omenn Gilbert S | Director | Grant(A) | 60K | — | $0 |
| Jan 16, 2026 | Amelio Gilbert F | Director | Grant(A) | 60K | — | $0 |
| Jan 16, 2026 | Uihlein Richard E | Director, 10% Owner | Grant(A) | 60K | — | $0 |
| Jan 16, 2026 | Schwartz Elissa J. | Director | Grant(A) | 60K | — | $0 |
| Jan 16, 2026 | Uihlein Richard E | Director, 10% Owner | Grant(A) | 13K | $3.04 | $40K |
| Jan 16, 2026 | Lewis Joel | President and CEO, Director | Grant(A) | 91K | — | $0 |
| Jan 16, 2026 | Carson Benjamin SR | Director | Grant(A) | 60K | — | $0 |
| Jan 16, 2026 | Zordani Richard A. Jr. | Director | Grant(A) | 60K | — | $0 |
| Jan 6, 2026 | Lewis Joel | President and CEO, Director | Sell(S) | 38K | $3.58 | $135K |
| Jan 6, 2026 | Jamil Khurram | Chief Medical Officer | Sell(S) | 21K | $3.65 | $78K |
| Jan 6, 2026 | Callicutt Jack W | Chief Financial Officer | Sell(S) | 20K | $3.67 | $75K |
| Jan 5, 2026 | Jamil Khurram | Chief Medical Officer | Sell(S) | 25K | $3.90 | $99K |
| Jan 5, 2026 | Callicutt Jack W | Chief Financial Officer | Sell(S) | 26K | $3.90 | $100K |
| Jan 5, 2026 | Lewis Joel | President and CEO, Director | disposed() | 56K | $3.88 | $219K |
| Jan 5, 2026 | Lewis Joel | President and CEO, Director | Sell(S) | 28K | $3.91 | $108K |
| Jan 2, 2026 | Lewis Joel | President and CEO, Director | Option exercise(M) | 84K | — | $0 |
| Jan 2, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 60K | — | $0 |
| Jan 2, 2026 | Callicutt Jack W | Chief Financial Officer | Sell(S) | 14K | $4.20 | $58K |
| Jan 2, 2026 | Lewis Joel | President and CEO, Director | Option exercise(M) | 84K | — | $0 |
| Jan 2, 2026 | Callicutt Jack W | Chief Financial Officer | Option exercise(M) | 60K | — | $0 |
| Jan 2, 2026 | Lewis Joel | President and CEO, Director | Sell(S) | 19K | $4.20 | $78K |
| Jan 2, 2026 | Jamil Khurram | Chief Medical Officer | Sell(S) | 13K | $4.20 | $55K |
| Jan 1, 2026 | Callicutt Jack W | Chief Financial Officer | Option exercise(M) | 60K | — | $0 |
| Jan 1, 2026 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 60K | — | $0 |
| Dec 31, 2025 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 8K | — | $0 |
| Dec 31, 2025 | Jamil Khurram | Chief Medical Officer | Sell(S) | 8K | $4.07 | $33K |
| Dec 31, 2025 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 8K | $1.23 | $10K |
| Dec 23, 2025 | Freeman Kevin D | Director | Buy(P) | 6K | $3.55 | $20K |
| Dec 23, 2025 | Freeman Kevin D | Director | Buy(P) | 6K | $3.55 | $20K |
| Dec 23, 2025 | Eldred Kary | Director | Buy(P) | 700 | $3.73 | $3K |
| Dec 23, 2025 | Freeman Kevin D | Director | Buy(P) | 6K | $3.55 | $20K |
| Dec 23, 2025 | Eldred Kary | Director | Buy(P) | 700 | $3.73 | $3K |
| Dec 17, 2025 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 6K | — | $0 |
| Dec 17, 2025 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 9K | — | $0 |
| Dec 17, 2025 | Lewis Joel | President and CEO, Director | Option exercise(M) | 8K | $2.86 | $22K |
| Dec 17, 2025 | Jamil Khurram | Chief Medical Officer | Sell(S) | 4K | $7.04 | $32K |
| Dec 17, 2025 | Lewis Joel | President and CEO, Director | Option exercise(M) | 8K | — | $0 |
| Dec 17, 2025 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 9K | $2.50 | $21K |
| Dec 17, 2025 | Jamil Khurram | Chief Medical Officer | Sell(S) | 6K | $7.04 | $45K |
| Dec 17, 2025 | Lewis Joel | President and CEO, Director | Sell(S) | 8K | $7.06 | $55K |
| Dec 17, 2025 | Shlevin Harold H. | Director | Sell(S) | 20K | $7.04 | $139K |
| Dec 17, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 20K | — | $0 |
| Dec 17, 2025 | Jamil Khurram | Chief Medical Officer | Option exercise(M) | 6K | $2.20 | $14K |
| Dec 17, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 20K | $1.98 | $40K |
| Dec 17, 2025 | Shlevin Harold H. | Director | Sell(S) | 5K | $7.04 | $33K |
| Dec 17, 2025 | Jamil Khurram | Chief Medical Officer | Sell(S) | 9K | $7.04 | $60K |
| Dec 16, 2025 | Czirr James C | 10% Owner | Sell(S) | 31K | $6.66 | $204K |
| Dec 15, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 8K | $4.16 | $35K |
| Dec 15, 2025 | Shlevin Harold H. | Director | Sell(S) | 8K | $6.30 | $53K |
| Dec 15, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 8K | — | $0 |
| Dec 12, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 20K | — | $0 |
| Dec 12, 2025 | Shlevin Harold H. | Director | Sell(S) | 20K | $6.27 | $124K |
| Dec 12, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 20K | $4.16 | $82K |
| Dec 9, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 17K | — | $0 |
| Dec 9, 2025 | Shlevin Harold H. | Director | Sell(S) | 17K | $6.27 | $105K |
| Dec 9, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 17K | $4.16 | $70K |
| Dec 8, 2025 | Shlevin Harold H. | Director | Sell(S) | 20K | $5.96 | $119K |
| Dec 8, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 25K | $1.72 | $43K |
| Dec 8, 2025 | Shlevin Harold H. | Director | Sell(S) | 4K | $6.01 | $24K |
| Dec 8, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 35K | $2.86 | $100K |
| Dec 8, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 35K | — | $0 |
| Dec 8, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 20K | $1.98 | $40K |
| Dec 8, 2025 | Shlevin Harold H. | Director | Sell(S) | 35K | $5.95 | $208K |
| Dec 8, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 20K | — | $0 |
| Dec 8, 2025 | Shlevin Harold H. | Director | Option exercise(M) | 20K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Galectin Therapeutics Inc, SEC CIK 0001133416. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under GALT and shows every filing by that issuer (also filed as GALT.OB, PRWP.OB, PRWP, PRW, PWRP.OB, 043562325).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for GALT